HDL-Targeted Therapies During Myocardial Infarction
Sign Up to like & getrecommendations! Published in 2019 at "Cardiovascular Drugs and Therapy"
DOI: 10.1007/s10557-019-06865-1
Abstract: It is now apparent that a variety of deleterious mechanisms intrinsic to myocardial infarction (MI) exists and underlies its high residual lethality. Indeed, despite effective coronary patency therapies, ischemia and reperfusion (I/R) injury accounts for… read more here.
Keywords: hdl targeted; therapies myocardial; myocardial infarction; infarction ... See more keywords
Nanocarrier-Based Targeted Therapies for Myocardial Infarction
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14050930
Abstract: Myocardial infarction is a major cause of morbidity and mortality worldwide. Due to poor inherent regeneration of the adult mammalian myocardium and challenges with effective drug delivery, there has been little progress in regenerative therapies.… read more here.
Keywords: targeted therapies; nanocarrier based; myocardial infarction; infarction ... See more keywords